Unlocking the role of EIF5A: A potential diagnostic marker regulating the cell cycle and showing negative correlation with immune infiltration in lung adenocarcinoma

Despite EIF5A upregulation related to tumor progression in LUAD (lung adenocarcinoma), the underlying mechanisms remain elusive. In addition, there are few comprehensive analyses of EIF5A in LUAD. We investigated the EIF5A expression level in LUAD patients using data from the TCGA and GEO databases....

Full description

Saved in:
Bibliographic Details
Published in:International immunopharmacology 2024-01, Vol.126, p.111227-111227, Article 111227
Main Authors: Yang, Zipeng, Yuan, Hao, He, Houjing, Qi, Shuting, Zhu, Xiaojing, Hu, Xiaoyu, Jin, Mengyuan, Zhang, Xiu-Xiang, Yuan, Zi-Guo
Format: Article
Language:English
Subjects:
Adenocarcinoma of Lung - diagnosis
Adenocarcinoma of Lung - immunology
Aged
Apoptosis
Biomarkers, Tumor - metabolism
Cell Cycle Checkpoints
Cell Line, Tumor
Cell Proliferation
Eukaryotic Translation Initiation Factor 5A - metabolism
Female
Humans
Lung Neoplasms - diagnosis
Lung Neoplasms - immunology
Male
Middle Aged
Signal Transduction
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Despite EIF5A upregulation related to tumor progression in LUAD (lung adenocarcinoma), the underlying mechanisms remain elusive. In addition, there are few comprehensive analyses of EIF5A in LUAD. We investigated the EIF5A expression level in LUAD patients using data from the TCGA and GEO databases. We employed qRT-PCR and western blot to verify EIF5A expression in cell lines, while immunohistochemistry was utilized for clinical sample analysis. We analyzed EIF5A expression in tumor-infiltrating immune cells using the TISCH database and assessed its association with immune infiltration in LUAD using the "ESTIMATE" R package. Bioinformatics approaches were developed to discover the EIF5A-related genes and explore EIF5A potential mechanisms in LUAD. Proliferation ability was verified through CCK-8, clone formation, and EdU assays, while flow cytometry assessed apoptosis and cell cycle. Western blot was used to detect the expression of pathway-related proteins. EIF5A was significantly upregulated in LUAD. Moreover, we constructed a MAZ-hsa-miR-424-3p-EIF5A transcriptional network. We explored the potential mechanism of EIF5A in LUAD and further investigated the cAMP signaling pathway and the cell cycle. Finally, we proved that EIF5A silencing induced G1/S Cell Cycle arrest, promoted apoptosis, and inhibited proliferation via the cAMP/PKA/CREB signaling pathway. EIF5A serves as a prognostic biomarker with a negative correlation to immune infiltrates in LUAD. It regulated the cell cycle in LUAD by inhibiting the cAMP/PKA/CREB signaling pathway.
ISSN:1567-5769
1878-1705
DOI:10.1016/j.intimp.2023.111227